Skip to main content
Premium Trial:

Request an Annual Quote

Cytox VariaTect SNP Array

Cytox has launched its VariaTect genetic biomarker test for assessing Alzheimer's disease risk. The array, developed for research use, offers a simple blood-based test that provides a comprehensive panel of AD-informative SNPs to assist in research and novel drug discovery studies. It uses a combination of whole exome association analysis, variants identified through genome wide association studies, and variants considered to be of importance in AD-associated biological pathways. This includes approximately 130,000 novel and known SNP variants in gene pathways implicated in AD aetiology. The test was developed in partnership with Thermo Fisher Scientific subsidiary Affymetrix, and will be marketed as the Axiom Dementia Research array.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.